Alan Parks, MD
Dermatology · Columbus, OHNPI 1598751653
Payments from drug & device makers
Across 343 payments — averaging $14.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$714
- Pfizer$573
- Prugen, Inc. Pharmaceuticals$348
- LEO Pharma Inc.$306
- E.r. Squibb & Sons, L.L.C.$202
- plus $1K from 21 others
What the payments were for
- Food & beverage$4,40990%
- Education$48510%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 157 | $1,509 |
| Johnson & Johnson | 25 | $714 |
| Pfizer | 48 | $573 |
| Prugen, Inc. Pharmaceuticals | 10 | $348 |
| LEO Pharma Inc. | 19 | $306 |
| E.r. Squibb & Sons, L.L.C. | 8 | $202 |
| Galderma Laboratories, L.p. | 9 | $146 |
| Bristol Myers Squibb | 9 | $136 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $110 |
| Amgen | 6 | $104 |
| Novartis | 6 | $100 |
| UCB, Inc. | 5 | $87 |
| Lilly USA, LLC | 5 | $74 |
| Dermavant Sciences, Inc. | 4 | $67 |
| Regeneron Healthcare Solutions, Inc. | 3 | $63 |
| Sanofi | 4 | $60 |
| Journey Medical Corporation | 4 | $60 |
| Mayne Pharma Commercial LLC | 3 | $44 |
| Almirall LLC | 2 | $40 |
| Dermira, Inc. | 2 | $39 |
| Merck | 1 | $19 |
| Aclaris Therapeutics, Inc. | 1 | $17 |
| Sun Pharmaceutical Industries Inc. | 1 | $16 |
| Encore Dermatology Inc. | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
| Taro Pharmaceuticals USA, Inc. | 1 | $15 |
| Strata Skin Sciences, Inc. | 1 | $14 |
How this compares
$4,894 in reported general payments places this provider in the 60th percentile of 460 dermatology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 11 | $40,545 |
| Fluocinonide | 169 | $9,029 |
| Triamcinolone Acetonide | 528 | $6,930 |
| Betamethasone Dipropionate | 91 | $6,453 |
| Desonide | 111 | $4,402 |
| Alclometasone Dipropionate | 97 | $3,430 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 50 | $3,390 |
| Doxycycline Hyclate | 121 | $2,974 |
| Butorphanol Tartrate | 13 | $2,866 |
| Metronidazole | 31 | $2,134 |
| CiclopiroxCiclopirox Olamine | 46 | $1,735 |
| Clindamycin Phosphate | 45 | $1,646 |
| Tretinoin | 22 | $1,530 |
| Ammonium Lactate | 68 | $1,189 |
| Mometasone Furoate | 42 | $986 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Columbus
- Jessica KaffenbergerColumbus$3.2M
- Benjamin BoguckiColumbus$2M
- Michelle ChambersColumbus$1.9M
- Kelly TylerColumbus$403K
- Nicholas BennerColumbus$356K
- Benjamin KaffenbergerColumbus$124K
- Stephanie FabbroColumbus$82K
- Shari Hicks-GrahamColumbus$68K
- Matthew ZirwasBexley$7.4M
- Neil KormanCleveland$6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.